Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 5;7(19):1513-9.
doi: 10.3969/j.issn.1673-5374.2012.19.011.

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations

Fei Di  1 , Tongyan Chen  2 , Hongli Li  3 , Jizong Zhao  1 , Shuo Wang  1 , Yuanli Zhao  1 , Dong Zhang  1
Affiliations

Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations

Fei Di et al. Neural Regen Res. .

Abstract

In this study, we determined the expression levels of matrix metalloproteinase-2 and -9 and matrix metalloproteinase tissue inhibitor-1 and -2 in brain tissues and blood plasma of patients undergoing surgery for cerebellar arteriovenous malformations or primary epilepsy (control group). Immunohistochemistry and enzyme-linked immunosorbent assay revealed that the expression of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 was significantly higher in patients with cerebellar arteriovenous malformations than in patients with primary epilepsy. The ratio of matrix metalloproteinase-9 to matrix metalloproteinase tissue inhibitor-1 was significantly higher in patients with hemorrhagic cerebellar arteriovenous malformations compared with those with non-hemorrhagic malformations. Matrix metalloproteinase-2 and matrix metalloproteinase tissue inhibitor-2 levels were not significantly changed. These findings indicate that an imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1, resulting in a relative overabundance of matrix metalloproteinase-9, might be the underlying mechanism of hemorrhage of cerebellar arteriovenous malformations.

Keywords: cerebellar arteriovenous malformations; enzyme-linked immunosorbent assay; hemorrhage; immunohistochemistry; matrix metalloproteinase-2; matrix metalloproteinase-9; neural regeneration; tissue matrix metalloproteinase inhibitor-1; tissue matrix metalloproteinase inhibitor-2.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared.

Figures

Figure 1
Figure 1
Expression of MMP-2, MMP-9, TIMP-1, and TIMP-2 in brain tissue in each group (immunohistochemistry). Cells positive for MMP-2/9 and TIMP-1/2 (arrows refer to immunopositive cells with brown-red granules) were located in the endochylema in the control and CAVM-N groups, and in vascular endothelial cells and vascular outer layer in the CAVM-H group. CAVM-H: Hemorrhagic patients with cerebral arteriovenous malformation; CAVM-N: non-hemorrhagic patients with cerebral arteriovenous malformation; MMP: matrix metalloproteinase; TIMP: matrix metalloproteinase tissue inhibitor.
See this image and copyright information in PMC

References

    1. Yasargil MG. New York: Georg Thieme Verlag; 1987. Microneurosurgery. IIIA: AVM of the brain, history, embryology, pathological considerations, hemodynamics, diagnostic studies, microsurgical anatomy.
    1. Hashimoto T, Wen G, Lawton MT, et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke. 2003;34(4):925–931. - PubMed
    1. Liu ZK, Lin ZM, Xu HZ, et al. Relationship between matrix metalloproteinase 9 and cerebral vascular malformations. Jilin Yixue. 2011;32(16):3175–3177.
    1. Kranzhöfer A, Baker AH, George SJ, et al. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thromb Vasc Biol. 1999;19(2):255–265. - PubMed
    1. Liu ZK, Lin ZM, Xu HZ, et al. Relation between matrix metalloproteinase 2 and cerebral vascular malformations. Jilin Yixue. 2011;32(19):3887–3888.